ERNA vs USB
Eterna Therapeutics Inc (ERNA) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the ERNA and USB stock pages for the full models.
Not investment advice.